Earnings History Data for iTeos Therapeutics (ITOS) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
iTeos Therapeutics
iTeos Therapeutics Inc. is a clinical-stage biopharmaceutical company. It engages in the discovery and development of immuno-oncology therapeutics. iTeos Therapeutics Inc. is based in Cambridge, United States.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 06-03-2024 | PM | ITOS | iTeos Therapeutics | 397.00 | -0.85 | -1.03 | 0.00 | iTeos Therapeutics GAAP EPS of -$0.85 beats by $0.18 [3/6/2024 7:29 AM] |
11.87 | 0.85 (7.71%) |
0.0 | 0.0 (0.00%) |
8.20 - 18.24 | 162,516 | 410,000 | 0 | ||
| 07-11-2023 | PM | ITOS | iTeos Therapeutics | 370.00 | -0.90 | -1.20 | 0.00 | iTeos Therapeutics GAAP EPS of -$0.90 beats by $0.30 [11/7/2023 8:26 AM] |
10.66 | 0.45 (4.41%) |
0.0 | 0.0 (0.00%) |
8.20 - 23.00 | 330,853 | 320,000 | 0 | ||
| 08-08-2023 | PM | ITOS | iTeos Therapeutics | 487.00 | -0.96 | -1.03 | 0.00 | iTeos Therapeutics GAAP EPS of -$0.96 [8/8/2023 8:02 AM] |
12.16 | -0.29 (-2.31%) |
0.0 | 0.0 (0.00%) |
12.13 - 27.52 | 130,778 | 180,000 | 0 | ||
| 10-05-2023 | PM | ITOS | iTeos Therapeutics | 504.00 | -0.44 | -0.99 | 0.00 | iTeos Therapeutics GAAP EPS of -$0.44 [5/10/2023 8:58 AM] |
14.53 | 0.35 (2.43%) |
0.0 | 0.0 (0.00%) |
12.52 - 28.05 | 132,046 | 200,000 | 0 | ||
| 15-03-2023 | PM | ITOS | iTeos Therapeutics | 571.00 | 0.57 | 0.42 | 0.00 | iTeos Therapeutics GAAP EPS of $0.54 [3/15/2023 8:30 AM] |
15.68 | -0.33 (-2.06%) |
0.0 | 0.0 (0.00%) |
15.43 - 37.26 | 229,086 | 240,000 | 0 | ||
| 10-08-2022 | AH | 4:00 PM ET (Aug 10) |
ITOS | iTeos Therapeutics | 960.00 | 0.15 | 1.20 | 0.00 | iTeos Therapeutics GAAP EPS of $0.16 misses by $1.04 [8/10/2022 4:54 PM] |
23.60 | -3.49 (-12.88%) |
26.99 | -0.10 (-0.37%) |
16.21 - 52.43 | 418,889 | 270,000 | 410 | |
| 10-11-2021 | AH | 4:00 PM ET (Nov 10) |
ITOS | iTeos Therapeutics, Inc. | 1,040 | 1.86 | 4.95 | -0.48 | iTeos Therapeutics reports Q3 results [11/10/2021 4:07 PM] |
29.63 | 0.20 (0.68%) |
30.50 | 1.07 (3.64%) |
17.43 - 47.61 | 161,359 | 140,000 | 1,300 | |
| 12-08-2021 | PM | 7:00 AM ET (Aug 12) |
ITOS | iTeos Therapeutics, Inc. | 877.95 | -0.75 | -0.41 | 0.00 | iTeos Therapeutics EPS misses by $0.28 [8/12/2021 7:12 AM] |
24.91 | -0.11 (-0.44%) |
24.91 | 0.0 (0.00%) |
17.43 - 47.61 | 293,991 | 180,000 | 2,177 | |
| 13-05-2021 | AH | 4:45 PM ET (May 13) |
ITOS | iTeos Therapeutics, Inc. | 810.79 | -0.39 | -0.48 | 0.00 | iTeos Therapeutics EPS beats by $0.09 [5/13/2021 4:45 PM] |
24.53 | 2.17 (9.70%) |
22.36 | 0.0 (0.00%) |
17.50 - 47.61 | 230,831 | 190,000 | 897 | |
| 24-03-2021 | AH | ITOS | iTeos Therapeutics, Inc. | 1,390 | -0.43 | -0.45 | 0.00 | iTeos Therapeutics EPS misses by $0.01 [3/24/2021 4:58 PM] |
32.27 | 1.41 (4.57%) |
0.0 | 0.0 (0.00%) |
17.50 - 47.61 | 294,183 | 430,000 | 0 | ||